ArticleInternational journal of oncology2016

Drug resistance originating from a TGF-β/FGF-2-driven epithelial-to-mesenchymal transition and its reversion in human lung adenocarcinoma cell lines harboring an EGFR mutation.

Ryota Kurimoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.